Zuckerberg backed-Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy

AI Summary

Cellular Intelligence, backed by Meta's Mark Zuckerberg, has successfully acquired Novo Nordisk's candidate for Parkinson’s cell therapy. This acquisition is poised to enhance the company's pipeline in advanced neural treatments.

May 11 (Reuters) - Meta CEO Mark Zuckerberg backed-Cellular Intelligence has acquired Danish drugmaker Novo Nordisk's cell therapy candidate ...